Security key
29405E208
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)
CUSIP: 29405E208
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 1,022,530
- Total 13F shares
- 187,040
- Share change
- -40,843
- Total reported value
- $630,094
- Price per share
- $3.37
- Number of holders
- 13
- Value change
- -$98,524
- Number of buys
- 7
- Number of sells
- 6
Report period
Q2 2023
Institutions
13
Top holders
10
ENVB full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29405E208
Recent filing periods:
Top shareholders of ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
|
Company |
14%
|
143,016
|
$240,267 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
29,578
|
$49,224 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
1.4%
|
14,129
|
$24,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
12,481
|
$20,968 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
12,125
|
$20,178 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
1%
|
10,683
|
$18,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.52%
|
5,318
|
$8,850 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
273
|
$459 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
150
|
$249 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
100
|
$166 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
29
|
$49 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2023 | |
| Carter Julian Ward |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
744,429
|
— | — | 19 Jan 2022 | |
| Thompson Bradley George |
3/4/5
|
Director |
—
class O/S missing
|
53,160
|
— | — | 16 Sep 2021 | |
| Avani Kanubaddi |
3/4/5
|
President and COO |
—
class O/S missing
|
48,346
|
— | — | 25 Jan 2023 | |
| Jillian Marie Hagel |
3/4/5
|
Vice President of Innovation |
—
class O/S missing
|
35,802
|
— | — | 25 Jan 2023 |
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q2 2023
As of 30 Jun 2023,
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
187,040 shares.
The largest 10 holders included
AdvisorShares Investments LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), ACADIAN ASSET MANAGEMENT LLC, GROUP ONE TRADING, L.P., BANK OF AMERICA CORP /DE/, and NATIONAL BANK OF CANADA /FI/.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
12
Q2 2023 holders
13
Holder diff
1
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.